Literature DB >> 4079335

Excretion of low-molecular weight volatile substances in human breath: focus on endogenous ethanol.

A W Jones.   

Abstract

This paper describes a gas chromatographic method suitable for the analysis of low-molecular endogenous volatiles in human breath. The use of an on-column gas sampling device allowed serial determinations at 10-min intervals. With a flame ionization detector and Porapak Q as stationary phase, the four major endogenous breath volatiles were methanol, ethanol, acetone, and isoprene (2-methyl-1,3-butadiene). These same compounds were present in the breath of healthy individuals and abstinent alcoholics. In 10 healthy men, the breath concentration of endogenous ethanol, methanol, and acetone ranged from 0.07 to 0.39 microgram/L, 0.21 to 0.07 microgram/L, and 0.57 to 4.01 micrograms/L, respectively. When a man drank 5 g of exogenous ethanol, the blood concentration increased 200 times above the endogenous level. This small dose of ethanol was eliminated with a half-life of 16 min.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4079335     DOI: 10.1093/jat/9.6.246

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  4 in total

1.  Concentration-time profiles of ethanol and acetaldehyde in human volunteers treated with the alcohol-sensitizing drug, calcium carbimide.

Authors:  A W Jones; J Neiman; M Hillbom
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

2.  Enhanced ethanol sensing properties of WO3 modified TiO2 nanorods.

Authors:  Bekzat Abdikadyr; Alp Kiliç; Onur Alev; Serkan Büyükköse; Zafer Ziya Öztürk
Journal:  Turk J Chem       Date:  2021-04-27       Impact factor: 1.239

3.  Inhalation pharmacokinetics of isoprene in rats and mice.

Authors:  H Peter; H J Wiegand; J G Filser; H M Bolt; R J Laib
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

4.  Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study.

Authors:  M Gruber; U Tisch; R Jeries; H Amal; M Hakim; O Ronen; T Marshak; D Zimmerman; O Israel; E Amiga; I Doweck; H Haick
Journal:  Br J Cancer       Date:  2014-07-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.